Disclosure Of Fair Value Measurement [Text Block]

AlzChem Group AG - Filing #6577157

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2022-01-01
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
422,860 EUR
377,667 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
276,914 EUR
288,103 EUR
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
145,946 EUR
15,316 EUR
1,934 EUR
121,044 EUR
1,009 EUR
101,763 EUR
87,451 EUR
144,012 EUR
24,981 EUR
88,128 EUR
87,630 EUR
101,127 EUR
101,763 EUR
1,934 EUR
89,564 EUR
1,009 EUR
51,104 EUR
24,981 EUR
1,009 EUR
101,127 EUR
24,981 EUR
89,564 EUR
51,104 EUR
87,630 EUR
88,128 EUR
1,934 EUR
101,763 EUR
53,077 EUR
88,128 EUR
101,763 EUR
68,658 EUR
81,356 EUR
24,981 EUR
66,895 EUR
1,763 EUR
0 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.